Transient elastography for diagnosis of hepatic fibrosis in people with alcoholic liver disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 5, 2013, Pages

  Pavlov, Chavdar S ^a,b   Casazza, Giovanni ^c   Nikolova, Dimitrinka ^a   Ivashkin, Vladimir T ^b   Gluud, Christian ^a  

^a University of Copenhagen   (Denmark)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TRANSIENT ELASTOGRAPHY;

EID: 85041504839     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010542     Document Type: Article

References (74)

1. Angulo P. Noninvasive assessment of fibrosis and steatosis in NASH and ASH. Gastroenterologie Clinique et Biologique 2009;33(10-11):940-8.
2. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, et al.Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23(5):1025-9.
3. Bercoff J, Tanter M, Fink M. Supersonic shear imaging: a new technique for soft tissue elasticity imaging. IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control 2004c;51(4):396-409.
4. BMI. www.nhlbi.nih.gov/guidelines/obesity/bmi_tbl.pdf (accessed 30 April 2013).
5. Bouchier IA, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. Journal of Hepatology 1992;16:290-7.
6. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology 1999;94(9):2467-74.
7. Caballeria J, Pares A, Bru C, Mercader J, Garcia Plaza A, Caballeria L, et al.Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial Spanish Group for the Study of Alcoholic Fatty Liver. Journal of Hepatology 1998;28(1):54-60.
8. Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut 2010;59(7):861-6.
9. Crespo G, Fernández-Varo G, Mariño Z, Casals G, Miquel R, Martínez SM, et al.ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. Journal of Hepatology 2012;57:281-7.
10. de Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastroentérologie Clinique et Biologique 2008;32(6 Suppl 1):58-67.
11. de Lédinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Review of Medical Devices 2010;7(6):811-23.
12. de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. Available from srdta.cochrane.org.
13. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58(9):882-93. [PUBMED: 16085191]
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
15. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic Injury. I. Performance characteristics of laboratory tests. Clinical Chemistry 2000;46:2027-49.
16. Echosens . FibroScan®: the essential for liver stiffness measurement. www.echosens.com/pdf/FS402_WEB.pdf. (accessed 30 April 2013).
17. Ersoz G, Demir A, Akarca OS, Yilmaz F, Ozutemiz O, Karasu Z, et al.The value of ultrasonography in the diagnosis of early cirrhosis. Turkish Journal of Gastroenterology 1999;10(1):7-10.
18. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-8.
19. Franciscus A. HCV diagnostic tools: grading and staging a liver biopsy (version 2.2). www.hcvadvocate.org (accessed 30 April 2013).
20. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al.Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134(4):960-74. [PUBMED: 18395077]
21. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology 2007;47(4):598-607.
22. Grant A. Guidelines on the use of liver biopsy in clinical practice. Gut 1999;45 Suppl 4:IV1-IV11. [DOI: 10.1136/gut.45.2008.iv1]
23. Gómez-Domínguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, García-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics 2006;24(3):513-8.
24. Hizli S, Kocyigit A, Arslan N, Tuncel S, Demircioglu F, Cakmakci H, et al.The role of ultrasonographic hepatic artery resistive index in the diagnosis of insulin resistance in obese children with non-alcoholic fatty liver disease. Turkish Journal of Medical Sciences 2010;40(3):335-42.
25. Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, et al.Applicability and variability of liver stiffness measurements according to probe position. World Journal of Gastroenterology 2009;15(27):3398-404.
26. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al.Histological grading and staging of chronic hepatitis. Journal of Hepatology 1995;22:696-9.
27. Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepatic Medicine: Evidence and Research 2011;3:69-80.
28. Ivashkin VT, Pavlov CS. Non-invasive diagnostic of liver fibrosis. Liver elastometry. In: Ivashkin VT, Pavlov CS editor(s). Liver Fibrosis. Moscow: Geotar-Media, 2011:76-85. [: ISBN 978-5-9704-1893-2]
29. Ivashkin VT, Pavlov CS. Liver biopsy and morphological investigation of chronic liver disease. In: Ivashkin VT, Pavlov CS editor(s). Liver Fibrosis. Geotar-Media, Moscow, 2011:13-22. [: ISBN 978-5-9704-1893-2]
30. Iyo AY. Acoustic radiation force impulse imaging: a literature review. Journal of Diagnostic Medical Sonography 2009;25(4):204-11.
31. Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, Srarkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. Journal of Clinical Gastroenterology 2010;44(8):575-82.
32. Jin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al.Assessment of hepatic fibrosis with magnetic resonance elastography. Clinical Gastroenterology and Hepatology 2007;5(10):1207-13.e2.
33. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282(11):1054-60.
34. Kim BK, Kim SU, Choi GH, Han WK, Park MS, Kim EH, et al."Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. Journal of Gastroenterology and Hepatology 2012;27(4):781-8.
35. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-21.
36. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
37. Kuntz E, Kuntz H-D. Hepatology. 3rd Edition. Heidelberg: Springer Medizin Verlag, 2008.
38. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54:729-37.
39. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al.Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282(11):1061-6.
40. Liu T, Wang X, Karsdal MH, Leeming DJ, Genovese F. Molecular serum markers of liver fibrosis. Biomark Insights 2012;7:105-17.
41. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. Available from srdta.cochrane.org.
42. Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T. FibroMAX: towards a new universal biomarker of liver disease?. Expert Review of Molecular Diagnostics 2007;7(5):481-90.
43. Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al.Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World Journal of Gastroenterology 2010;16(8):966-72.
44. Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Lédinghen V, Douvin C, et al.Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. Journal of Hepatology 2008;49:1062-8.
45. Nahon P. Noninvasive markers of fibrosis in alcoholic liver disease [Marqueurs non invasifs de fibrose dans la maladie alcoolique du foie]. Gastroentérologie Clinique et Biologique 2009;33(12):1154-6.
46. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25(1):108-11.
47. Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, et al.Assessment of asymptomatic liver fibrosis in alcoholic patients using FibroScan: prospective comparison with seven non-invasive laboratory tests. Alimentary Pharmacology and Therapeutics 2008;28(10):1188-98.
48. O'Shea RS, Dasarathy S, McCullough AJ, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Alcoholic Liver Disease. Hepatology 2010;51(1):307-28.
49. Pavlov CS, Gluschenkov D, Konovalova ON, Nikolova D, Ivashkin VT, Gluud C. Ultrasonography for diagnosis of hepatic fibrosis and cirrhosis in patients with alcoholic liver disease. Cochrane Database of Systematic Reviews Issue [to be submitted for publication 2013].
50. ® alone for diagnosis of hepatic fibrosis in adult patients with chronic hepatitis C. Cochrane Database of Systematic Reviews [to be submitted for publication 2013].
51. Poulsen HE, Christoffersen P. Atlas of Liver Biopsies. Copenhagen: Munksgaard, 1979.
52. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, et al.Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterology 2007;7:40. [DOI: doi:10.1186/1471-230X-7-40]
53. Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D. Assessment of liver fibrosis: noninvasive means. The Saudi Journal of Gastroenterology 2008;14(4):163-73.
54. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al.Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. American Journal of Gastroenterology 2002;97(10):2614-8.
55. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology. 2005/09/20 2005; Vol. 58, issue 10:982-90.
56. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
57. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134(1):8-14.
58. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. Journal of Hepatology 2008;48(4):606-13.
59. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. Canadian Medical Association Journal 2006;174(4):469-76.
60. Rutter CA, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20:2865-84.
61. Sackett D, Haynes RB. The architecture of diagnostic research. BMJ 2002;324:539-41.
62. Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, et al.Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology 2003;29:1705-13.
63. Savolainen VT, Liesto K, Männikkö A, Penttilä A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcoholism, Clinical and Experimental Research 1993;17:1112-7.
64. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, et al.Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clinical Gastroenterology and Hepatology 2010;8:877-83.
65. Sherlock S, Dooley J. Alcohol and the liver. Diseases of the Liver and Biliary System. 10th Edition. Oxford: Blackwell Science, 1997:385-403.
66. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, et al.Quality of reporting of diagnostic accuracy studies. Radiology 2005;235:347-53.
67. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al.A meta-analysis of transient elastography for the detection of hepatic fibrosis. Journal of Clinical Gastroenterology 2010;44(3):214-9.
68. Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends in Molecular Medicine 2001;7(9):408-13.
69. Sorensen TIA, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;ii:241-4.
70. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis and fibrosis in pure alcoholic fatty liver. Lancet 1995;356:987-90.
71. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. Journal of Hepatology 2011;54(4):650-9.
72. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine 2004;140(3):189-202.
73. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology 2005;5:19.
74. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529-36.